Recent News

• 09.09.2025 - Modeyso™ (dordaviprone) Included in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for H3 K27M-mutant Diffuse Glioma
• 09.09.2025 - Modeyso™ (dordaviprone) Included in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for H3 K27M-mutant Diffuse Glioma
• 09.03.2025 - Jazz Pharmaceuticals at 2025 Wells Fargo Healthcare Conference
• 09.03.2025 - Jazz Pharmaceuticals at 2025 Wells Fargo Healthcare Conference
• 08.27.2025 - Modeyso Investor Webcast
• 08.27.2025 - Modeyso Investor Webcast
• 08.27.2025 - Modeyso Investor Webcast
• 08.27.2025 - Modeyso Investor Webcast
• 08.21.2025 - Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference
• 08.21.2025 - Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference

Recent Filings

• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities